Guannan Gong

Guannan’s research is to explore different digital phenotyping approaches based on electronic healthcare data, and to identify the state of the art pipeline for detection of adverse events, such as oncology patients developing bleeds post treatment, and identification of patients who are eligible for clinical trials based on inclusion and exclusion criteria.